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Abstract Obstructive sleep apnoea (OSA) is a common disorder with numerous potential sequelae. Although the
majorityofthese consequences canbereducedwith appropriate treatment, onlylimiteddata existregarding the natural
progression ofthis disorder inuntreated individuals.
Weherebyreportalong-termfollow-upof alluntreatedpatients (n¼40) followed-upintheTechnion SleepClinic, using
both subjective and objectivemeasurements.In addition, we report a long-term follow-up of11patientswho attempted
dietaryweight loss.
Theaveragetimeintervalbetweenthe first andsecondpolysomnographies for theuntreatedgroupwas 5?072?8 yrs,
and 2?572?3 yrs for theweightreduction group.Therewasno significantchange in Body Mass Index (BMI) or Respira-
toryDisturbance Index (RDI) betweenthetwoPolysomnographic (PSG) evaluationsintheuntreatedpatients.However,
eight patients developed hypertension (n¼5) or ischaemic heartdisease (IHD) (n¼3) betweenthe two evaluations.RDI,
age and BMIatthetime ofthe initialevaluationwerenotpredictive ofchangesin RDI, snoringintensityorminimaloxygen
saturation.However, the patientswho developed hypertension/IHDhad significantly higher RDI than the patientswho
did not (46727 vs. 23717 h1, Po0?005). In the weight-loss group,BMI decreased by a mean of 3?1kgm2, and RDI
decreased by 20 eventsh1, Po0?05 for both.Therewas a significantcorrelation betweentheweight loss and improve-
ment in RDI (R¼0?75, P¼0?005).
We conclude that in untreated obstructive sleep apnoea patients RDI does not necessarily increase over time,
but associated hypertension or ischaemic heart disease may develop.When weight loss is successfully achieved, sleep
apnoea significantly improveswith a high correlation betweenthe extentof weight loss and the improvement in apnoea
status.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1277, available online at http://www.idealibrary.comon
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Obstructive sleep apnoea (OSA) is a common disorder
characterized by the repetitive collapse of the pharyn-
geal airway during sleep. Its prevalence is 2^4%, and the
potentially associated sequelae include reduced quality
of life, increased risk of motor vehicle accidents, hyper-
tension, and possibly an increased frequency of myocar-
dial infarction and stroke.While treatment is associated
with a reduction in these consequences, the literature
regarding the natural progression of the disorder aswellReceived19April 2001and accepted in revised form 26November 2001.
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Fax: (972)-4-8323045; E-mail: plavie@tx.technion.ac.ilas long-term follow-up of therapy is relatively sparse. As
treatment of OSA can be poorly tolerated, the risk and
bene¢t of no therapy is of clinical importance. The stu-
dies that have addressed this issue, were usually either
subjective (questionnaire based) or with relatively
short-term follow-up.The results of these revealed con-
£icting conclusions.
In a retrospective study of 118 OSA patients, Lugaresi
et al. reported that typical patients had snored for many
years prior to developmentof OSA.They concluded that
this is a progressive disease which starts with simple
snoring and evolves to full-blown OSA syndrome with
increased severity (1). Likewise, Martikainen et al. found
in a population-based questionnaire study that the pre-
valence of self-reported snoring and pauses between
snoring increased in a 5yr follow-up study (2). In the
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untreated OSA patients objectively, two found that
mild^moderate OSA may indeed progress over a rela-
tively short period of time (3,4), while two others
reported that the severity of OSA is stable over
time (5,6).
In the non-apnoea elderly population the ¢ndings are
also inconclusive. Phoda et al. (7) and Bliwise et al. (8) re-
portedmild increases in apnoea indices over time (3 and
5yrs, respectively) in these populations. In contrast, An-
coli-Israel et al. (9) found no change with high variability
of RDI in a triple evaluation study over an 8?5yrs
period.
In a recent study, Lindberg et al. (10) reported a long-
term follow-up of 29 men with untreated snoring and
daytime somnolence. A repeat PSG10 years after initial
evaluation revealed that 18 had similar RDI between the
two studies, while in 11 the RDI increased by more than
5h1.While in the ¢rst evaluation only one man had an
RDI of above 10h1, after 10 yrs eight men fell into this
category. This increase in RDI of snorers could not be
predicted by any of the baseline measurements (e.g.
RDI, BMI, age, or smoking). The group in whom RDI
deteriorated did not di¡er from the‘stable’group inwor-
sening of EDS or development of HTN.This study, how-
ever, was limited by the population selection of only
snorers and not patients with OSA.
As there are only few data in the literature regarding
the natural history of apnoea indices in OSA patients,
based mainly on relatively short-term follow-up, we
planned this study to evaluate changes in apnoea severity
andpotential sequelae in all untreatedpatients followed-
up in our clinic. We hypothesized that patients who
choose not to be treated will have relatively mild OSA,
and that they would demonstrate deterioration over
long-term follow-up both subjectively and objectively.
For comparison, we also present data of follow-up of 11
patients who underwent a dietary weight loss program,
with somewhat shorter follow-up time.
METHODS
Subjects
Alluntreatedpatientswhowere followed-up in our clinic
and underwent re-evaluation polysomnography (PSG),
were included in the study. In addition, followed-up pa-
tients whowere in our clinic after participation in a diet-
ary program of weight loss were included as well.These
patients who participated in weight reduction programs
were instructed to return for a follow-up study once
they reached a stable targetweight. Patientswho under-
went a surgical procedure (nasal: septoplasty/turbinect-
omy, or pharyngeal: LAUP/UPPP) or were on continuous
treatment with either continuous positive airway pres-sure (CPAP) or oral appliance were excluded. All un-
treated patients in the study were recommended to be
treated but chose not to due to either non-compliance
with CPAP/dental device or refusal of surgery or both.
None of the patients had major otolaryngologic pathol-
ogy on ENTexamination. All the participants were re-
quired to evaluate subjectively the spontaneous changes
which occurredbetween the two sleep studies regarding
snoring intensity and daytime somnolence. Each patient
underwent a medical interview including completing
sleep questionnaires, Epworth Sleepiness Scale, brief
physical examination including weight and height mea-
surements by the same sleep physician in our lab, and a
full night PSG sleep study.Concomitant diseases (speci¢-
cally, HTN and IHD) were de¢ned based on diagnosis
made by other specialists (PCP,Cardiologist), regardless
of this study, and were retrieved from the patients’
primary care physician records.
Polysomnography
All patients underwent two full-night PSG studies, with
the identical equipment (Nihon Kohden polygraph, EEG-
4214,Tokyo, Japan).Recordings consisted of electroence-
phalography (EEG) (C3-A2), electrooculography (EOG),
submental electromyography (EMG), electrocardiogra-
phy (ECG), £ow (thermistor), respiratory e¡ort (thor-
acic belt), and legmovements.Data were recorded both
on paper (with a paper speed of1cm sec1), and on com-
puter.Bedtimewas between 22:00^23:00 and 06:00 (all
patients were awakened at 06:00). In addition, quantita-
tive snoring intensity and arterial oxygen saturation
levels were continuously recorded. An oxygen satura-
tion sensor was placed on the ¢fth ¢nger of each subject,
and a microphone was placed one meter above the
patient’s bed.
Scoring andde¢nitions
All scoring was performed based on standard criteria
(11). Apnoeawas de¢ned as the complete cessation of air-
£ow for at least 10 sec. Hypopnoea was de¢ned as any
decrement in £ow, if it was associated with either arou-
sal (de¢ned as the appearance of 3 sec of alpha rhythm in
the EEG or an increment in submental EMG signal) or
oxygen desaturation (of 3% or more). Respiratory Dis-
turbance Index was calculated by dividing the total
number of apnoeas + hypopnoeas by total sleep time.
The minimal oxygen saturation was determined as the
lowest saturation value that was associated with a re-
spiratory event (i.e. excluding artifactually low values
due to movements). Likewise, maximal snoring intensity
was determined as themaximal decibels recordedby the
dB-meter, associated with snoring (i.e. excluding cough
or other noises).
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were de¢ned as a reduction or increment of 25% or
more of the initial RDI, if the change was at least 10
events per h (i.e. to avoid calling a change from an RDI
of10 to13 ‘worsening’. In this example ‘worsening’ would
require at least 20 events per h).These arbitrary de¢ni-
tions were prespeci¢ed.
Data analysis
All statistical analyses were performed with commer-
cially available software (Excel 97, Microsoft; and Sigma-
Stat, SPSS, Chicago). All data are presented as mean71
SD unless otherwise stated. Two-tailed t-tests for inde-
pendent samples were used to compare variables be-
tween groups or subgroups, and paired t-test to
statistically assess the impact of time within patient
groups. In each case, Po0?05 was taken to indicate
signi¢cance.
RESULTS
Summarydata for theuntreated andweight loss patients
is shown inTable1.The average time intervalbetween the
¢rst and second polysomnographies for the untreated
group was 572?8yrs, and 2?572?3yrs for the weightTABLE 1. Comparison of measurements between untreated a
long-term follow-up evaluation
Variable
Numberof patients (M/F)
Age at ¢rst study (yrs)
Timebetween studies (yrs)
BMI (kgm2) First
Second
RDI (eventsh1) First
Second
Minimal Oxygen Sat (%) First
Second
Maximal Snoring intensity (dB) First
Second
Hypertension Number (%) First
Second
IHDNumber (%) First
Second
Subjective change (No. of patients) Improved
Unchange
Worsened
Values aremean7SD.
BMI: bodymass index;RDI:Respiratory Disturbance Index;IHD:
IHDand subjective changes are presented as numberof patients
*Po0?05 Between ¢rst and follow-up studies.
wPo0?05 between groups.reductiongroup. In theweight-loss group, BMI decreased
by a mean of 3?1kgm2, and RDI decreased by 20
eventsh1,Po0?05 for both (Table1).Therewas a signi¢-
cant correlation between the weight loss (BMI) and im-
provement in RDI (R¼0?75, P¼0?005). In the untreated
group, there was no signi¢cant change in BMI or RDI
(Table 1). There was no signi¢cant correlation between
changes in weight (BMI) and in RDI in the untreated
group. Minimal oxygen saturation in the untreated
patients worsened (88710 vs. 85711%, Po0?05), and
maximal snoring intensity increased (6078 vs. 6578dB,
Po0?05). Eight untreated patients developed hyperten-
sion (n¼5) or ischaemic heart disease (n¼3) over the
time course of 5 yrs between the two evaluations
(Table 1). None of the patients in the weight
reduction group developed HTN or IHD during the
study period.
The Epworth Sleepiness Scale (ESS) score did not
di¡er between the two evaluations (9?274?5 and
9?474?9, respectively). Although 19 patients reported
worsening of their complaints, there was no signi¢-
cant objective change in their ESS score (8?774?2
and 10?675?0 on the ¢rst and second evaluations,
respectively).
The severity of the disorder, patients’ BMI or age at
the time of the initial evaluation could not predict
changes in RDI, snoring intensity or minimal oxygennd weight loss patients, and between primary evaluation and
Untreated Weight loss
40 (36/4) 11 (11/0)
47710 46713
5?072?8 2?572?3
28?974?8 33?374?5
29?474?6 30?273?6*
27721 46717}
28721 26716*
88710 82710
85711* 8576
6078 67710
6578* 6575
6 (15) 4 (36)
11 (28) 4 (36)
2 (5) 0
5 (13) 0
0 3
d 22 7
18 1
Ischaemic Heart Disease; dB: decibeles.Values forhypertension,
(percentage in brackets).
TABLE 2. Change in RDIin di¡erent subgroups ofthe untreatedpatients based on severity,BMI and age
Category Subgroup classi¢cation
based on ¢rst study
Number (Patients
in category)
Time between
studies (mo)
RDIAt ¢rst
evaluation
RDI at second
evaluation
RDI Mild (0^20) 23 54737 13?475?0 16?575?9
Moderate (21^40) 10 62733 33?078?3 28?7710?9
Severe (440) 7 81722 64?7718?6 61?6724?6
BMI Lean (o25) 7 27711?6 13?473?3 12?773?4
Overweight (25^30) 20 66733?7 23?3716?2 20?1712?9
Obese (430) 13 71735?8 40?8726?9 39?7728?3
Age o40 8 45736?2 12?877?5 16?074?1
40^50 19 64737?7 26?1720?0 25?4717?3
450 13 66729?4 37?9724?1 39?2+26?9
All the patients presented in this tablewere untreated.Time betweenthe two evaluations is presented inmonths.In none ofthe
subgroups (in all categories) was the change in RDIbetweenthe two PSGevaluations signi¢cant.
TABLE 3. Comparisonbetweenuntreatedpatients inwhom RDIworsened, and those inwhomit improved
Group (Alluntreated) n Age (yrs) BMIkgm2 RDI eventshour1
First Second First Second First Second
Improved 5 56714 63714 3074 3073 4579 26711
Worsened 6 4578 5278 3074 3073 21722 38725
TABLE 4. Comparisonbetweenuntreatedpatientswithnewlydiagnosed HTN/IHDand the others
Group (Alluntreated) n Age (yrs) BMIkgm2 RDIeventshour1 Oximin (%)
First Second First Second First Second First Second
HTN/IHD 8 5779* 6379* 3375* 3275 46727* 46731* 78712* 81711
Others 32 4578 5079 2874 2975 23717 23715 9078 85711
The patients who developed HTN/IHD were older, heavier and had more severe OSA at the initial evaluation than those in
whom these diseases were not newly diagnosed.However, the diseases were developed despite tendency to reduce BMI in this
group as opposed to increased BMI in the other group, such that in the second evaluation the BMIs did not di¡er signi¢cantly be-
tweenthe groups.
*Po0?05 betweengroups.
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subgroups according to RDI, BMI and age is presented in
Table 2. In none of the subgroups was the change in RDI
between the two PSG evaluations signi¢cant. In ¢ve pa-
tients the RDI in the second studydecreased (improved),
while in other six it increased (worsened). Characteris-
tics of these two subgroups are shown inTable 3.The ‘im-
proved’ group consisted of older patients with worse
RDI than the ‘worsened’ group. Data of the patients
who developed hypertension/ischaemic heart disease
during the study period are presented inTable 4. These
patients were signi¢cantly older (57 vs. 45 yrs, Po0?05)
andhad signi¢cantlyhigherRDI than the other untreatedpatients (46727 vs. 23717h1, Po0?05). Interestingly,
they were also heavier at the time of diagnosis, but they
tended to reduce weight compared to the others who
tended to gain weight, such that at the time of second
evaluation the BMIs of the two groups were similar.
There were no di¡erences in other risk factors of HTN/
IHD such as smoking habits (1/8 and 4/32, respectively),
hyperlipidaemia (1/8 and 2/32, respectively), diabetes
mellitus (1/8 and 2/32, respectively) and alcohol con-
sumption (0/8 and 3/32, respectively) among thepatients
who developed cardiovascular consequence and those
who did not.The subjective evaluation of change in slee-
piness/snoring between the two groups was also similar.
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The results of this study suggest that untreated patients
with obstructive sleep apnoea syndrome do not
necessarily worsen over time, as manifested by similar
respiratory disturbance indices. Although relatively
long-term follow-up (5yrs on the average) PSG evalua-
tion of untreated patients revealed in this study some-
what deeper oxygen desaturations and increased
intensity of snoring, the clinical relevance of this is un-
clear. The respiratory disturbance index remained un-
changed over 5 yrs of follow-up. None of the tested
variables could predict which patients would worsen
andwhichwould not.
Trying to conclude regarding the natural history of
OSA from a combination of our results with results of
previous studies, we believe that OSA is a very gradually
progressive disorder.We speculate that it starts with a
long period of indolent snoring (1), then progresses to a
relatively rapid period of increased frequency of respira-
tory events (3,12), again followed by relatively stable
status (5) with potential mild worsening of snoring and
oxygen desaturations, as we observed in the present
study. In the absence of weightgain, it is impossible at this
time to predict which patient will deteriorate andwhich
will not. Both in the present study, and in the previous
studies that reported deterioration of apnoea with
time, neither age nor BMI correlated with the change in
RDI (10).
The fact that in the two studies reporting deteriora-
tion, the RDI was mild-moderate, and in the study that
reported stable RDI, it was severe, raises the possibility
of a ceiling e¡ect.However, the ¢ndings of this studyplus
those of Rosenthal et al., that even with low RDIs there
is not necessarily progression, somewhat oppose this
theory. Likewise, it could be argued that a threshold
e¡ect caused increase in RDI in the Svanborg study (12),
however, again, we and others (6,9) found that evenwith
low RDI there is not necessarily deterioration with time
(Table 2). Furthermore, the very mild change of
minimal oxygen saturation recorded in the second
evaluation of the untreated group is within the
con¢dence limits for this measure, and its clinical
relevance is unclear.
Night-to-night variability in RDI can undoubtedly play
a role in the ¢ndings of this as well as all the abovemen-
tioned papers. It has been previously shown that night-
to-night variability in RDI can be as high as730% (13,14).
Thus, our, and others’ (5), attempt to distinguish patients
who ‘improved’ from those who ‘worsened’ on an indivi-
dual basis is potentially problematic. For a large group,
however, it can be assumed that this random variability
will be self-canceling. In addition, it is unlikely that ‘¢rst-
night’ e¡ect plays a role given the long time duration
between the two studies. Therefore, the group ¢nding
of increased ODI from 10?1 to 20?9 over 15?6 months(12), and of RDI from 21?8 to 33?4 over 17 months (3),
probablyre£ects a realworseningrather thanvariability.
Likewise, the RDI stability we found as well as that re-
portedbyothers (5) is also probably real andnot a result
of nightly variability. One possible explanation for the
con£icting results is that the patients in the Svandborg
and Pendlebury studies (3,12) were still in the ‘rapid
deterioration phase’ of the disorders, whereas
those in Sforza’s study and in the current one were be-
yond that period.We do not know whether the patients
in the Sforza study tended to develop hypertension, as
this information was not given in that study. In the
present study, however, ¢ve out of 34 developed this
over a 5-yr period (15%), which is substantially higher
than the expected 3^4% incidence of newly diagnosed
hypertension in the general population over a
similar period (15). This brings us to the conclusion
that even in the absence of RDI deterioration,OSA may
continue to progress gradually, with worsening oxygen
desaturations and posing a risk for associated diseases
such as hypertension (16).However, the patientswho de-
veloped new hypertension or ischaemic heart disease
were older and heavier than those who did not, which
could also contribute to the development of these
diseases.
The ¢nding that in the weight-loss group, signi¢cant
weight loss was associated with signi¢cant reduction in
RDI, is consistent with many previous works (17^22).
While these studies have followed up these patients for
0?5^2yrs, in the present study the follow-up period is
2?572?3yrs. As previous studies failed to demonstrate
correlation between the amount of weight loss and the
improvement in apnoea indices (17,18), it was unclear
whether a critical threshold level for weight loss exists,
and which patients were most likely to bene¢t from
treatment. The ¢nding in the present study, of a signi¢-
cant correlation between the weight loss and improve-
ment in RDI (R¼0?75, P¼0?005), supports the concept
that any patient may bene¢t from weight loss, without
such a critical threshold.
Our study has several limitations:
(1) Although we chose an unselected group, namely
took all patients who were followed-up in our clinic,
the groupmaybebiasedby the fact thatonlypatients
who came to the clinic were analyzed. We cannot
predict what would have been the status of
untreated patients who had not returned to clinic.
One could argue that the most symptomatic would
likely return for visits. Alternatively, the most
severely a¡ected patients may have been forced
into treatment or succumbed to their disease
(23,24). In order to minimize sampling bias from
this population, we chose to study all eligible
individuals rather than a speci¢c severity or sub-
group.
342 RESPIRATORYMEDICINE(2) The number of subjects who participated in this
study is too small to draw conclusions regarding the
natural history of OSA. However, given that they
were followed up both subjectively and objectively
for a relatively long period of time, we believe these
¢ndings are important and add to the existing
literature. In addition, although only 40 patients
participated, these were all eligible individuals, with
no patients dropping out due to missing data or
technical problems.
(3) The follow-up period of the weight loss group is
shorter than that of the untreated group. As a
result, their OSA severity could have changed over
an additional 2?5yrs of follow up. Previously, we
assessed OSA patients, both at short and long
periods after weight reduction surgery, and
found that they improved in the short-term
following surgery, but again worsened in
long-term follow-up (25). Anatomical abnormalities
of the upper airway may also be important in
predicting the e¡ect of weight loss (26). However,
again, we did not ¢nd gross ENT abnormalities in
our patients.
(4) Using a patients’/family physician’s report as the
source of diagnosis of hypertension or ischaemic
heart disease may result in underdiagnosis of the
problems, since only symptomatic patients were
probably diagnosed. Possibly this represents the
lower limit of cardiovascular complications in
patients with OSA (27). Including cardiologic
evaluation in the protocol may have improved the
accuracy of these cardiovascular complications
evaluations. However, we believe the new onset
diagnosis of these complications could equally
be made in all patients and therefore believe the
results have not been skewed in any particular
direction.
In conclusion, the most striking observations of this
study are the relatively stable RDIs in untreatedOSApa-
tients over a 5-yr period.RDI, age and BMI at the time of
the initial evaluation were not predictive of changes in
RDI, snoring intensity or minimal oxygen saturation, but
thepatientswho developedhypertension/IHDhad signif-
icantlyhigherRDI than thepatientswho didnot.Dietary
weight reduction is an e¡ective treatment in a ‘dose’-
related fashion.
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